company background image
RVTY logo

Revvity NYSE:RVTY Stock Report

Last Price

US$112.56

Market Cap

US$13.5b

7D

-2.9%

1Y

4.5%

Updated

20 Dec, 2024

Data

Company Financials +

Revvity, Inc.

NYSE:RVTY Stock Report

Market Cap: US$13.5b

RVTY Stock Overview

Provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. More details

RVTY fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance3/6
Financial Health5/6
Dividends0/6

Rewards

Trading at 15.9% below our estimate of its fair value

Earnings are forecast to grow 19.57% per year

Earnings grew by 20.5% over the past year

Analysts in good agreement that stock price will rise by 23%

Risk Analysis

Large one-off items impacting financial results


My Notes

Capture your thoughts, links and company narrative

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WA
Analyst Price Target
Consensus Narrative from 18 Analysts

Operational Improvements And AI Applications In Diagnostics Will Drive Future Efficiencies

Key Takeaways Operational improvements and AI-driven solutions are poised to enhance workflow efficiencies and drive future revenue growth. Share repurchase authorization and strategic innovations suggest strong cash flow and potential EPS growth.
View narrative
US$138.68
FV
18.8% undervalued intrinsic discount
6.39%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
2 days ago author updated this narrative

Revvity, Inc. Competitors

Avantor

NYSE:AVTR

US$14.3b

Qiagen

NYSE:QGEN

US$9.9b

Bio-Techne

NasdaqGS:TECH

US$11.3b

Waters

NYSE:WAT

US$21.4b

Price History & Performance

Summary of share price highs, lows and changes for Revvity
Historical stock prices
Current Share PriceUS$112.56
52 Week HighUS$129.50
52 Week LowUS$97.32
Beta1.03
1 Month Change1.10%
3 Month Change-8.41%
1 Year Change4.50%
3 Year Change-41.91%
5 Year Change15.98%
Change since IPO3,298.04%

Recent News & Updates

Why Revvity, Inc. (NYSE:RVTY) Could Be Worth Watching

Dec 19
Why Revvity, Inc. (NYSE:RVTY) Could Be Worth Watching

Safe Biopharma: Revvity's Recurring Revenues And Diagnostics

Dec 16

Estimating The Intrinsic Value Of Revvity, Inc. (NYSE:RVTY)

Dec 01
Estimating The Intrinsic Value Of Revvity, Inc. (NYSE:RVTY)

We Think Revvity's (NYSE:RVTY) Healthy Earnings Might Be Conservative

Nov 13
We Think Revvity's (NYSE:RVTY) Healthy Earnings Might Be Conservative

Recent updates

Why Revvity, Inc. (NYSE:RVTY) Could Be Worth Watching

Dec 19
Why Revvity, Inc. (NYSE:RVTY) Could Be Worth Watching

Safe Biopharma: Revvity's Recurring Revenues And Diagnostics

Dec 16

Estimating The Intrinsic Value Of Revvity, Inc. (NYSE:RVTY)

Dec 01
Estimating The Intrinsic Value Of Revvity, Inc. (NYSE:RVTY)

We Think Revvity's (NYSE:RVTY) Healthy Earnings Might Be Conservative

Nov 13
We Think Revvity's (NYSE:RVTY) Healthy Earnings Might Be Conservative

Here's Why Revvity (NYSE:RVTY) Can Manage Its Debt Responsibly

Oct 24
Here's Why Revvity (NYSE:RVTY) Can Manage Its Debt Responsibly

Getting In Cheap On Revvity, Inc. (NYSE:RVTY) Might Be Difficult

Aug 21
Getting In Cheap On Revvity, Inc. (NYSE:RVTY) Might Be Difficult

When Should You Buy Revvity, Inc. (NYSE:RVTY)?

Jul 16
When Should You Buy Revvity, Inc. (NYSE:RVTY)?

Revvity: Continued Struggles, 2024 Becoming A Lost Year

Jul 03

Is Revvity (NYSE:RVTY) Using Too Much Debt?

Jun 10
Is Revvity (NYSE:RVTY) Using Too Much Debt?

Why We're Not Concerned About Revvity, Inc.'s (NYSE:RVTY) Share Price

Apr 03
Why We're Not Concerned About Revvity, Inc.'s (NYSE:RVTY) Share Price

Revvity: Enter Now As Reorganization Takes Shape

Mar 21

We Think Revvity (NYSE:RVTY) Can Stay On Top Of Its Debt

Feb 28
We Think Revvity (NYSE:RVTY) Can Stay On Top Of Its Debt

Investors Can Find Comfort In Revvity's (NYSE:RVTY) Earnings Quality

Feb 13
Investors Can Find Comfort In Revvity's (NYSE:RVTY) Earnings Quality

Should You Think About Buying Revvity, Inc. (NYSE:RVTY) Now?

Jan 19
Should You Think About Buying Revvity, Inc. (NYSE:RVTY) Now?

An Intrinsic Calculation For Revvity, Inc. (NYSE:RVTY) Suggests It's 49% Undervalued

Jan 04
An Intrinsic Calculation For Revvity, Inc. (NYSE:RVTY) Suggests It's 49% Undervalued

Revvity: More Than A Name Change Is Needed For PerkinElmer

Dec 29

Revvity: Recent Investments, Acquisitions, Not Pulling Economic Weight (Rating Downgrade)

Oct 04

Revvity: New Name - But New Investment Outlook? Reiterate Buy

Jul 18

Shareholder Returns

RVTYUS Life SciencesUS Market
7D-2.9%-2.1%-2.4%
1Y4.5%-5.5%23.3%

Return vs Industry: RVTY exceeded the US Life Sciences industry which returned -6.6% over the past year.

Return vs Market: RVTY underperformed the US Market which returned 22.1% over the past year.

Price Volatility

Is RVTY's price volatile compared to industry and market?
RVTY volatility
RVTY Average Weekly Movement3.8%
Life Sciences Industry Average Movement9.2%
Market Average Movement6.3%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: RVTY has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: RVTY's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
193711,500Prahlad Singhwww.revvity.com

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

Revvity, Inc. Fundamentals Summary

How do Revvity's earnings and revenue compare to its market cap?
RVTY fundamental statistics
Market capUS$13.45b
Earnings (TTM)US$258.26m
Revenue (TTM)US$2.72b

53.0x

P/E Ratio

5.0x

P/S Ratio

Is RVTY overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RVTY income statement (TTM)
RevenueUS$2.72b
Cost of RevenueUS$1.21b
Gross ProfitUS$1.51b
Other ExpensesUS$1.25b
EarningsUS$258.26m

Last Reported Earnings

Sep 29, 2024

Next Earnings Date

n/a

Earnings per share (EPS)2.12
Gross Margin55.37%
Net Profit Margin9.49%
Debt/Equity Ratio40.2%

How did RVTY perform over the long term?

See historical performance and comparison

Dividends

0.2%

Current Dividend Yield

13%

Payout Ratio

Does RVTY pay a reliable dividends?

See RVTY dividend history and benchmarks
When do you need to buy RVTY by to receive an upcoming dividend?
Revvity dividend dates
Ex Dividend DateJan 17 2025
Dividend Pay DateFeb 07 2025
Days until Ex dividend27 days
Days until Dividend pay date48 days

Does RVTY pay a reliable dividends?

See RVTY dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 05:21
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/29
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Revvity, Inc. is covered by 43 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Catherine Ramsey SchulteBaird
Ishan MajumdarBaptista Research
Luke SergottBarclays